Synapse - Works

Results (4073)

Beyond Jeopardy!: Harnessing IBM's Watson to improve oncology decision making

Meeting Abstract

Bach, P.; Zauderer, M. G.; Gucalp, A.; Epstein, A. S.; Norton, L.; Seidman, A. D.; Caroline, A.; Grigorenko, A.; Bartashnik, A.; Wagner, I.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Preliminary safety, product parameters, and immune response assessments from a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy (ACI), in patients (pts) with surgically resected HER2+ urothelial cancer (UC) at high risk for recurrence

Meeting Abstract

Bajorin, D. F.; Sharma, P.; Lerner, S. P.; Sims, R. B.; Sanders, A.; DeVries, T.; Sheikh, N. A.; Gomella, L. G.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

A pooled analysis of 1,546 patients with AIDS-related lymphoma (ARL): An assessment of prognostic factors by treatment era

Meeting Abstract

Barta, S. K.; Samuel, M.; Xue, X.; Lee, J. Y.; Mounier, N.; Kaplan, L. D.; Ribera, J. M.; Spina, M.; Tirelli, U.; Weiss, R.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Rituximab pharmacokinetics in children and adolescents with de novo intermediate and advanced mature B-cell lymphoma/leukemia: A Children's Oncology Group (COG) report

Meeting Abstract

Barth, M. J.; Goldman, S.; Smith, L.; Perkins, S. L.; Shiramizu, B.; Gross, T. G.; Harrison, L.; Sanger, W.; Geyer, M. B.; Giulino, L. B.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Association of bone scan index (BSI) with prognostic biomarkers and survival in men with metastatic castration-resistant prostate cancer (mCRPC) enrolled in a prospective randomized controlled trial of tasquinimod

Meeting Abstract

Armstrong, A. J.; Kaboteh, R.; Carducci, M. A.; Damber, J. E.; Stadler, W. M.; Mats, H.; Edenbrandt, L.; Forsberg, G.; Nordle, O.; Pili, R.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

ERG rearrangements and association with clinical outcome in patients (pts) receiving abiraterone acetate (AA): Results from the COU-AA-302 study in chemotherapy (chemo)-naïve metastatic castration-resistant prostate cancer (mCRPC)

Meeting Abstract

Attard, G.; De Bono, J. S.; Li, W.; Molina, A.; Griffin, T. W.; Kheoh, T. S.; Ricci, D. S.; Zelinsky, K.; Rathkopf, D. E.; Scher, H. I.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)

Meeting Abstract

Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Phase II randomized study of dalantercept in combination with axitinib compared to axitinib alone as second-line treatment in patients with metastatic renal cell carcinoma

Meeting Abstract

Atkins, M. B.; Bhatt, R. S.; Voss, M. H.; Rini, B. I.; Jonasch, E.; Plimack, E. R.; Alter, R.; Barger, R.; Wilson, D.; McClure, T.; more...
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)

Meeting Abstract

Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save

Breast cancer risk prediction using the novel germ-line signatures in epigenome regulatory pathways

Meeting Abstract

Adaniel, C.; Rendleman, J.; Smith, J. A.; Klein, R. J.; Schnabel, F. R.; Shao, Y. Z.; Offit, K.; Kirchhoff, T.
Journal of Clinical Oncology (2013)

Fulltext@MSK | Save